Immuno-Oncology Symposium, Therapeutic Developments I: Head and Neck Cancer: Kevin Harrington Published 2019-09-06 Download video MP4 360p Download video MP4 720p Recommendations 1:04:37 T cells, cancer and immunity 03:14 Treatments for Head and Neck Cancer (Squamous Carcinoma Tumor) 1:14:20 Dementia could start in your blood vessels - eat these foods to keep your mind sharp | Dr William Li 1:00:41 Predicting HPV association using deep learning in oropharyngeal cancer: Sebastian Klein, 13/05/24 10:49 Mary Lou Retton on Life Following Near-Death Mystery Illness: Why She Needed Fundraising (Exclusive) 12:51 Why a Zurich Forensic Professor Drives with a Dolphin in HK | Prof Michael Thali | TEDxCityUHongKong 12:30 Psychiatric Interviews for Teaching: Psychosis 09:30 5 ways to naturally boost the 'Ozempic Effect' | Jason Fung 02:42 Recent advances in targeted therapy for head and neck cancer 05:35 World Economic Forum Ideas Lab AMNC15: Laura Nyström - Food Waste 17:00 Psychosis & Schizophrenia Mnemonics (Memorable Psychiatry Lecture) 05:19 Enhancing muscle use through better understanding of nutrient delivery | Katrien De Bock 1:11:31 Pauli Lectures 2016: The Structural Biochemical Mechanism of Synaptic Neurotransmission in the Brain 10:51 CU#120. Life maintenance. 11:16 Multiple sclerosis - causes, symptoms, diagnosis, treatment, pathology 12:59 ASH 2023 - Multiples Myelom: Kommentar Prof. Christoph Renner, Zürich 34:49 05 - Minoryx Therapeutics Update by Marc Martinell (PhD, Co-Founder & CEO of Minoryx Therapeutics) 11:25 Understanding Parkinson's Disease (Including Direct and Indirect Pathways) 10:37 Acid Sphingomyelinase Deficiency: Answers To Frequently Asked Questions With Neal Weinreb, MD 29:50 20 - Update on Gene Therapy for Childhood Cerebral ALD by Dr. Vinod Prasad (bluebird bio) Similar videos 12:20 Professor Kevin Harrington 31:38 Clinical results, patient cases and future developments II: Head & neck cancer – Kevin Harrington 27:51 Oracle Research Event 2019 Kevin Harrington: Radiotherapy 17:17 Research Evening 2018 Presentation - Professor Kevin Harrington 2018 03:08 Improved survival, toxicity & QoL with pembrolizumab in head and neck cancer 01:59 Potential of immunotherapy in head and neck cancer 03:20 Professor Kevin Harrington discusses the important role of the Oracle Cancer Trust - part 1 03:01 Update on oncolytic viruses for cancer treatment 06:21 Goals of Therapy for HNSCC 02:37 Challenges of combining SOC chemotherapy/radiotherapy and immunotherapy in head and neck cancer 00:58 Checkpoint inhibitors for head and neck cancer in the definitive setting? 06:31 Kevin Harrington CCR med.m4v.mp4 08:37 Immune-Based Approaches in the Curative Setting of HNSCC 10:59 Emerging Concepts for Immunotherapy in HNSCC 1:17:21 Head & Neck Cancer Symposium: New Technologies and Patient Care Delivery Panel 28:07 Zurich Immuno-Oncology Symposium, Therapeutic Developments II: Hemato-Oncology: Markus Manz 01:05 Drug development and clinical trials for immunotherapy and radiosensitising drugs 01:17 Dr. Ferris on FDA Approval of Nivolumab in Patients With Head and Neck Cancer More results